
FDA Panel's Doubts on Antidepressants in Pregnancy Raise Concerns
An FDA panel questioned the safety of SSRIs during pregnancy, citing studies that many experts say are misrepresented or flawed, leading to criticism from medical societies. Most evidence indicates SSRIs are safe for pregnant women, and untreated depression poses significant health risks. Experts emphasize the importance of accurate information and a range of treatment options, including therapy and medication, to support maternal mental health.





